News tagged with bone marrow disease
Key bone marrow protein identified as potential new leukemia treatment target
A new study on how the progression of acute lymphocytic leukemia (ALL) is influenced by the bone marrow environment has demonstrated for the first time that targeting a specialized protein known as osteopontin (OPN) may be ...
Cancer
Apr 15, 2013 |
not rated yet |
0
Manipulating calcium accumulation in blood vessels may provide a new way to treat heart disease
Hardening of the arteries, or atherosclerosis, is the primary cause of heart disease. It is caused by calcium accumulation in the blood vessels, which leads to arteries becoming narrow and stiff, obstructing blood flow and ...
Cardiology
Apr 09, 2013 |
5 / 5 (1) |
1
Cells predict onset of graft-versus-host disease in men receiving BMTs from female donors
Stanford University School of Medicine investigators have identified a clutch of cells that—if seen in a male patient's blood after receiving a brand-new immune system in the form of a bone-marrow transplant from a female ...
Medical research
Feb 04, 2013 |
4 / 5 (1) |
0
|
Landmark study in blood stem cell transplant
(Medical Xpress)—Before all the excitement about embryonic stem cells, doctors were using hematopoetic – that is, blood-forming—stem cells. Hematopoetic stem cells can replenish all the types of cells in the blood, ...
Medical research
Jan 04, 2013 |
5 / 5 (2) |
0
|
Boosting immune responses against leukaemia
(Medical Xpress)—In the first of its kind, a translational study undertaken at the Malaghan Institute of Medical Research has revealed that boosting the activity of a rare type of immune cell could be an ...
Cancer
Nov 21, 2012 |
5 / 5 (1) |
0
Brain displays an intrinsic mechanism for fighting infection
(Medical Xpress)—White blood cells have long reigned as the heroes of the immune system. When an infection strikes, the cells, produced in bone marrow, race through the blood to fight off the pathogen. ...
Medical research
Nov 19, 2012 |
5 / 5 (3) |
2
|
Synribo approved to treat rare leukemia
(HealthDay)—Synribo (omacetaxine mepesuccinate) has been approved by the U.S. Food and Drug Administration to treat a rare blood and bone marrow disease called chronic myelogenous leukemia (CML).
Cancer
Oct 26, 2012 |
not rated yet |
0
Father of bone marrow transplant is dead at 92
E. Donnall Thomas, a physician who pioneered bone marrow transplants and later won the 1990 Nobel Prize in medicine, has died in Seattle at age 92.
Other
Oct 21, 2012 |
not rated yet |
0
Leading bone marrow transplant expert recommends significant change to current practice
One of the world's leading bone marrow transplant experts is recommending a significant change to current transplant practice for patients who need marrow or adult stem cells from an unrelated donor to treat hematologic malignancies. ...
Other
Oct 17, 2012 |
not rated yet |
0
|
Bone marrow holds secrets for treating colitis and Crohn's
(Medical Xpress)—Michigan State University researchers have unlocked secrets in bone marrow that could lead to improved treatments for colitis and Crohn's disease.
Medical research
Sep 24, 2012 |
not rated yet |
0
|
'Half-match' bone marrow transplants wipe out sickle cell disease in selected patients
In a preliminary clinical trial, investigators at Johns Hopkins have shown that even partially-matched bone marrow transplants can eliminate sickle cell disease in some patients, ridding them of painful and debilitating symptoms, ...
Medical research
Sep 20, 2012 |
not rated yet |
0
|
Researchers restore children's immune systems with refinements in gene therapy
Researchers have demonstrated that a refined gene therapy approach safely restores the immune systems of some children with severe combined immunodeficiency (SCID). The rare condition blocks the normal development of a newborn's ...
Immunology
Sep 11, 2012 |
5 / 5 (3) |
0
|
Improved diagnostic test benefits children with acute myeloid leukemia
Early treatment response is a powerful predictor of long-term outcome for young patients with acute myeloid leukemia (AML). The information can help physicians decide whether a more intensive approach is needed. Research ...
Cancer
Sep 10, 2012 |
not rated yet |
0
New genetic clues to why most bone marrow transplant patients develop graft-versus-host disease
A team of scientists led by a bone marrow transplant researcher at Fred Hutchinson Cancer Research Center has shed new light on why most bone marrow transplant patients who receive tissue-matched cells from unrelated donors ...
Medical research
Sep 04, 2012 |
4 / 5 (1) |
0
|
Tapping the body to fight disease
Biju Parekkadan saw his future in the plight of a newborn thousands of miles away.
Medical research
Sep 03, 2012 |
not rated yet |
0
